Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts

Parkinson’s Disease (PD) is characterized both by the loss of dopaminergic neurons in the substantia nigra and the presence of cytoplasmic inclusions called Lewy Bodies. These Lewy Bodies contain the aggregated α-synuclein (α-syn) protein, which has been shown to be able to propagate from cell to ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Teil, Margaux, Arotcarena, Marie-Laure, Faggiani, Emilie, Laferriere, Florent, Bezard, Erwan, Dehay, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175302/
https://www.ncbi.nlm.nih.gov/pubmed/32138193
http://dx.doi.org/10.3390/biom10030391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175302/
https://www.ncbi.nlm.nih.gov/pubmed/32138193
http://dx.doi.org/10.3390/biom10030391

Ejemplares similares